YU16578A - Process for obtaining a serum protein preparation - Google Patents

Process for obtaining a serum protein preparation

Info

Publication number
YU16578A
YU16578A YU00165/78A YU16578A YU16578A YU 16578 A YU16578 A YU 16578A YU 00165/78 A YU00165/78 A YU 00165/78A YU 16578 A YU16578 A YU 16578A YU 16578 A YU16578 A YU 16578A
Authority
YU
Yugoslavia
Prior art keywords
obtaining
serum protein
protein preparation
serum
preparation
Prior art date
Application number
YU00165/78A
Other languages
English (en)
Inventor
M Radovitz
Original Assignee
Plasmesco Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AT0185977A external-priority patent/AT367297B/de
Application filed by Plasmesco Ag filed Critical Plasmesco Ag
Publication of YU16578A publication Critical patent/YU16578A/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/76Albumins
    • C07K14/765Serum albumin, e.g. HSA
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065Purification, fragmentation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827Proteins from mammals or birds
    • Y10S530/829Blood
    • Y10S530/83Plasma; serum
    • Y10S530/831Cohn fractions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
YU00165/78A 1977-01-26 1978-01-24 Process for obtaining a serum protein preparation YU16578A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH93477 1977-01-26
AT0185977A AT367297B (de) 1977-03-17 1977-03-17 Verfahren zur herstellung eines serumeiweiss-pr[parates

Publications (1)

Publication Number Publication Date
YU16578A true YU16578A (en) 1983-10-31

Family

ID=25597003

Family Applications (1)

Application Number Title Priority Date Filing Date
YU00165/78A YU16578A (en) 1977-01-26 1978-01-24 Process for obtaining a serum protein preparation

Country Status (23)

Country Link
US (1) US4216205A (de)
JP (1) JPS5396315A (de)
AR (1) AR220328A1 (de)
AU (1) AU522413B2 (de)
BE (1) BE863278A (de)
DD (1) DD133632A5 (de)
DE (1) DE2801123C2 (de)
DK (1) DK152334C (de)
EG (1) EG13119A (de)
ES (1) ES466385A1 (de)
FI (1) FI63673C (de)
FR (1) FR2378524A1 (de)
GB (1) GB1597204A (de)
HU (1) HU182554B (de)
IE (1) IE46304B1 (de)
IL (1) IL53856A (de)
IN (1) IN147713B (de)
NL (1) NL7800606A (de)
PL (1) PL124730B1 (de)
SE (1) SE447204B (de)
SU (1) SU786854A3 (de)
YU (1) YU16578A (de)
ZA (1) ZA78295B (de)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4351710A (en) * 1980-01-10 1982-09-28 Ionics, Incorporated Fractionation of protein mixtures
FR2492269A2 (fr) * 1980-01-10 1982-04-23 Ionics Appareil d'electrodialyse et procede de fractionnement de melanges de proteines
US4322275A (en) * 1980-01-10 1982-03-30 Ionics Incorporated Fractionation of protein mixtures
US4321192A (en) * 1980-01-10 1982-03-23 Ionics Incorporated Fractionation of protein mixtures by salt addition followed by dialysis treatment
EP0072843A1 (de) * 1981-02-18 1983-03-02 University Patents, Inc. Niederschlag von proteinen
US4452893A (en) * 1981-08-03 1984-06-05 Cutter Laboratories, Inc. Cell growth medium supplement
US4391801A (en) * 1981-10-29 1983-07-05 Cutter Laboratories, Inc. Plasma protein fraction substantially free of acetate ions
US4439421A (en) * 1982-08-30 1984-03-27 Baxter Travenol Laboratories, Inc. Stabilized gamma globulin concentrate
DE3245591C2 (de) * 1982-12-09 1986-11-06 Schott Glaswerke, 6500 Mainz Verfahren zur fraktionierten Auftrennung von Stoffgemischen mit Membranen
US4486282A (en) * 1983-02-22 1984-12-04 University Patents, Inc. Precipitation of proteins from salt-containing proteinaceous fluids employing a desalting treatment, and use thereof in selective plasmapheresis
DE3344656A1 (de) * 1983-12-09 1985-06-13 Lentia GmbH Chem. u. pharm. Erzeugnisse - Industriebedarf, 8000 München Verfahren zur herstellung einer serumproteinloesung
US5420250A (en) * 1990-08-06 1995-05-30 Fibrin Corporation Phase transfer process for producing native plasma protein concentrates
CA2066374C (en) * 1991-04-19 2002-01-29 Paul E. Segall Solution for perfusing primates
CN1055095C (zh) * 1992-12-11 2000-08-02 上海莱士血制品有限公司 白蛋白的纯化方法
US6627393B2 (en) 1993-06-04 2003-09-30 Biotime, Inc. Solutions for use as plasma expanders and substitutes
US5945272A (en) 1993-06-04 1999-08-31 Biotime, Incorporated Plasma expanders and blood substitutes
US6680305B1 (en) * 1993-06-04 2004-01-20 Biotime, Inc. Physiologically acceptable aqueous solutions and methods for their use
EP0701455B1 (de) 1993-06-04 2001-03-14 Biotime, Inc. Plasma-artige lösung
US6300322B1 (en) 1993-06-04 2001-10-09 Biotime, Inc. Plasma-like solution
US6218099B1 (en) 1994-06-03 2001-04-17 Biotime, Inc. Methods and compositions for use in perfusion applications
US6589223B1 (en) * 1999-02-03 2003-07-08 Biotime, Inc. Method and compositions for use in perfusion applications
US6441144B1 (en) 1999-05-20 2002-08-27 Alpha Therapeutic Corporation Method for repairing dual virally inactivated immune globulin for intravenous administration
US6596262B2 (en) * 2001-02-15 2003-07-22 Aeropharm Technology Incorporated Modulated release particles for aerosol delivery
US6806355B2 (en) * 2001-08-14 2004-10-19 Statens Serum Institut Purification process for large scale production of Gc-globulin, the Gc-globulin produced hereby, a use of Gc.globulin and a Gc-globulin medicinal product
CA2742994A1 (en) * 2008-11-12 2010-05-20 Baxter International Inc. Purification of butyrylcholinesterase using membrane adsorption
AU2010202125B1 (en) * 2010-05-26 2010-09-02 Takeda Pharmaceutical Company Limited A method to produce an immunoglobulin preparation with improved yield
US8772462B2 (en) 2010-05-26 2014-07-08 Baxter International Inc. Removal of serine proteases by treatment with finely divided silicon dioxide
US8796430B2 (en) 2010-05-26 2014-08-05 Baxter International Inc. Method to produce an immunoglobulin preparation with improved yield
CN110054685A (zh) * 2019-04-26 2019-07-26 兰州兰生血液制品有限公司 一种静注人免疫球蛋白(pH4)低温乙醇组分Ⅲ的生产方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1207477A (en) * 1969-04-29 1970-10-07 Ts I Gematologii I Perelivania Plasma proteins solution
US3770631A (en) * 1971-06-29 1973-11-06 Baxter Laboratories Inc Clarification of blood serum and plasma
JPS5620287B2 (de) * 1972-06-19 1981-05-13
US4073886A (en) * 1973-01-30 1978-02-14 Baxter Travenol Laboratories, Inc. Blood fractionation process using block copolymers of ethylene oxide and polyoxypropylene
US3850903A (en) * 1973-06-21 1974-11-26 S Mankarious Plasma volume expander prepared from cohn iv precipitate using block copolymers of ethylene oxide and polyoxypropylene
DE2459291C3 (de) * 1974-12-14 1981-06-04 Biotest-Serum-Institut Gmbh, 6000 Frankfurt Verfahren zur Herstellung eines antihämophiles Globulin A enthaltenden Konzentrats neben einem Prothrombin- Komplex und einer Lösung von lagerstabilen Serumproteinen

Also Published As

Publication number Publication date
US4216205A (en) 1980-08-05
DE2801123C2 (de) 1986-01-02
FR2378524B1 (de) 1983-02-04
NL7800606A (nl) 1978-07-28
DE2801123A1 (de) 1978-07-27
PL204214A1 (pl) 1978-09-25
DK152334B (da) 1988-02-22
SE7800443L (sv) 1978-07-27
DD133632A5 (de) 1979-01-17
ES466385A1 (es) 1978-10-01
AR220328A1 (es) 1980-10-31
HU182554B (en) 1984-02-28
DK35478A (da) 1978-07-27
FI780212A (fi) 1978-07-27
EG13119A (en) 1981-03-31
DK152334C (da) 1988-07-25
JPS5396315A (en) 1978-08-23
ZA78295B (en) 1978-12-27
FI63673B (fi) 1983-04-29
IN147713B (de) 1980-06-07
GB1597204A (en) 1981-09-03
AU3260078A (en) 1979-07-26
BE863278A (nl) 1978-05-16
AU522413B2 (en) 1982-06-03
SU786854A3 (ru) 1980-12-07
IE46304B1 (en) 1983-04-20
FR2378524A1 (fr) 1978-08-25
SE447204B (sv) 1986-11-03
IL53856A (en) 1981-03-31
IE780088L (en) 1978-07-26
PL124730B1 (en) 1983-02-28
FI63673C (fi) 1983-08-10
JPS6241211B2 (de) 1987-09-02

Similar Documents

Publication Publication Date Title
YU16578A (en) Process for obtaining a serum protein preparation
YU112779A (en) Process for obtaining a novel complex preparation
YU232082A (en) Process for preparing phthalazine-4-yl-acetic acids
JPS5452151A (en) Serum clarifying method
JPS53130423A (en) Reagent for immunochemical analysis method
RO79320A (ro) Procedeu de preparare a unor 4-piperidinamine
YU216278A (en) Process for determining alpha-amilase
RO81114A (ro) Procedeu de preparare a unor 4-desacetilvincalencoblastin-c3-carboxihidracide
PT68900A (en) Process for preparing novel peptide compounds
YU309978A (en) Process for obtaining stabilized biochemical preparations
GB2008090B (en) Process for preparing 2-hydroxynaphthalene-carboxylic acids
PT68978A (en) Process for preparing peptide derivatives
RO78358A (ro) Procedeu de preparare a unor 3-tiometilcefalosporine
MY8100309A (en) Process for the preparation of a vegetable protein extract
RO75804A (ro) Procedeu de preparare a unor cefalosporine
DE2860880D1 (en) Method for preparing stabilized carrier-bound proteins
RO80087A (ro) Procedeu de preparare a unor tiazoliliden-oxo-propionitrili
JPS5424839A (en) Process for preparing trifluoromethylphenol
GB2007363B (en) Process for determining ferritin
RO79154A (ro) Procedeu de preparare a unor cefalosporine
YU41322B (en) Process for obtaining polypeptides
YU191678A (en) Process for preparing new 2-pyridyl-and 2-pyrimidylaminobenzoic acids
RO84256A (ro) Procedeu de preparare a unor iminohalogenuri de cefalosporina
PT68938A (en) Process for preparing peptide derivatives
YU114780A (en) Process for obtaining h-sar-lys-sar-gln-nh2 peptides